scholarly journals Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole

2016 ◽  
Vol Volume 9 ◽  
pp. 6029-6036 ◽  
Author(s):  
Shengliang Sun ◽  
Fuchao Wang ◽  
Honglei Dou ◽  
Longqiang Zhang ◽  
Jiwen Li
Keyword(s):  
Breast Cancer ◽  
Zoledronic Acid ◽  
Bone Loss ◽  
Aromatase Inhibitor ◽  
Cancer Patients ◽  
Postmenopausal Breast Cancer ◽  
Breast Cancer Patients ◽  
Preventive Effect

Aromatase inhibitor-associated arthralgia: Prevalence, clinical and serum parameters among Turkish postmenopausal breast cancer patients

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 11525-11525 ◽  
Author(s):  
H. Harputluoglu ◽  
O. Dizdar ◽  
F. Unsal Malas ◽  
L. Ozcakar ◽  
N. Bulut ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Aromatase Inhibitor ◽  
Cancer Patients ◽  
Postmenopausal Breast Cancer ◽  
Breast Cancer Patients ◽  
Serum Parameters

Higher than expected estradiol levels in aromatase inhibitor-treated, postmenopausal breast cancer patients

Climacteric ◽  
2012 ◽  
Vol 15 (5) ◽  
pp. 473-480 ◽  
Author(s):  
T. Kunovac Kallak ◽  
J. Baumgart ◽  
A. Stavreus Evers ◽  
I. Sundström Poromaa ◽  
L. Moby ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Aromatase Inhibitor ◽  
Cancer Patients ◽  
Postmenopausal Breast Cancer ◽  
Breast Cancer Patients ◽  
Estradiol Levels

scholarly journals Survival Benefit of Zoledronic Acid in Postmenopausal Breast Cancer Patients Receiving Aromatase Inhibitors

2014 ◽  
Vol 17 (4) ◽  
pp. 350 ◽  
Author(s):  
Sung Gwe Ahn ◽  
Sung Hyun Kim ◽  
Hak Min Lee ◽  
Seung Ah Lee ◽  
Joon Jeong
Keyword(s):  
Breast Cancer ◽  
Zoledronic Acid ◽  
Cancer Patients ◽  
Aromatase Inhibitors ◽  
Survival Benefit ◽  
Postmenopausal Breast Cancer ◽  
Breast Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document